These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7016069)

  • 1. Staging of breast cancer: a new rationale for internal mammary node biopsy.
    Morrow M; Foster RS
    Arch Surg; 1981 Jun; 116(6):748-51. PubMed ID: 7016069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET for axillary lymph node staging in primary breast cancer.
    Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
    Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
    Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary biopsy compared with dissection in the staging of lymph nodes in operable breast cancer. A randomised trial.
    Christensen SB; Jansson C
    Eur J Surg; 1993 Mar; 159(3):159-62. PubMed ID: 8102890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
    Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
    Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic significance of internal mammary lymph node metastases in breast cancer patients].
    Noguchi M; Ota N; Koyazaki N; Taniya T; Miyazaki I; Mizukami Y
    Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):295-9. PubMed ID: 1513310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients.
    Heuts EM; van der Ent FW; von Meyenfeldt MF; Voogd AC
    Eur J Surg Oncol; 2009 Mar; 35(3):252-7. PubMed ID: 18684584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes.
    Veronesi U; Cascinelli N; Greco M; Bufalino R; Morabito A; Galluzzo D; Conti R; De Lellis R; Delle Donne V; Piotti P
    Ann Surg; 1985 Dec; 202(6):702-7. PubMed ID: 3000303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
    Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
    Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stage migration after biopsy of internal mammary sentinel lymph node in breast cancer patient].
    Deliĭski T
    Khirurgiia (Sofiia); 2005; (2):26-7. PubMed ID: 18681144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of axillary lymph node micrometastases in breast cancer.
    Sakorafas GH; Geraghty J; Pavlakis G
    Eur J Surg Oncol; 2004 Oct; 30(8):807-16. PubMed ID: 15336724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internal mammary sentinel lymph node biopsy should still be performed, especially in the patient with clinically positive axillary lymph nodes.
    Qiu PF; Zhao RR; Liu YB; Wang YS
    Breast; 2013 Oct; 22(5):999-1000. PubMed ID: 23838319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive parameters for internal mammary node drainage in patients with early breast cancer.
    Lukesova L; Vrana D; Gatek J; Koranda P; Cwiertka K; Radova L; Melichar B; Prouzova Z; Sramek V; Svach I
    Tumori; 2014; 100(3):254-8. PubMed ID: 25076234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative assessment of axillary lymph node metastases in operable breast cancer.
    Noguchi M; Minami M; Earashi M; Taniya T; Miyazaki I; Mizukami Y; Nonomura A
    Breast Cancer Res Treat; 1996; 40(2):179-85. PubMed ID: 8879684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting nodal metastases in breast cancer by lymphoscintigraphy.
    Hill NS; Ege GN; Greyson ND; Mahoney LJ; Jirsch DW
    Can J Surg; 1983 Nov; 26(6):507-9. PubMed ID: 6627140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
    Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
    Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidental internal mammary lymph node biopsy in 113 cases of breast cancer undergoingfree abdominal flap breast reconstruction and its influencing factors].
    Quan CL; Huang NS; Yang BL; Wang Y; Cao AY; Zhang YY; Huang XY; Chen JJ; Shen ZZ; Shao ZM; Wu J
    Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):769-773. PubMed ID: 27784463
    [No Abstract]   [Full Text] [Related]  

  • 19. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer.
    Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
    Arch Surg; 1993 Feb; 128(2):242-6. PubMed ID: 8094282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of internal mammary node dissection in the treatment of breast cancer.
    Horino T; Fujita M; Ueda N; Ota J; Ryo M; Nakano Y; Taguchi T
    Jpn J Clin Oncol; 1991 Dec; 21(6):422-7. PubMed ID: 1805047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.